Haemato-oncology treatment in Singapore

Diong Colin Phipps

Blood · Singapore

Dr Colin Phipps is a haematologist practising at Mount Elizabeth Hospitals and Gleneagles Hospital, Singapore. He specialises in lymphoma and blood cancers, and haematopoietic stem cell transplantation. Dr Phipps received his medical degree from the National University of Ireland in 2002 and subsequently completed internal medicine residency and specialist training in haematology at Singapore General Hospital (SGH). He was awarded the HMDP fellowship to pursue subspecialty training in lymphoma and bone marrow transplantation at the renowned Fred Hutchinson Cancer Research Centre in Seattle. Dr Phipps spent 10 years with the department of haematology at SGH. There, he was appointed as lymphoma director in 2012 and helped build the lymphoma programme, later becoming the lymphoma lead for the SingHealth-DUKE Blood Cancer Centre, which brought together lymphoma teams from SGH and National Cancer Centre Singapore. He has overseen the management of hundreds of patients with complex blood cancers, including resistant lymphomas and those undergoing transplantation. He also headed numerous pharmaceutical-sponsored and investigator-initiated clinical trials that have allowed patients access to many novel treatments. Dr Phipps is actively involved in undergraduate and postgraduate training of young doctors in Singapore. He has held roles including postgraduate mentor and senior lecturer with NUS Yong Loo Lin School of Medicine, as well as MBBS examiner and assistant adjunct professor with DUKE-NUS Medical School. He has authored more than 30 papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as advisor to numerous regional and international expert panels and education programmes.

Diong Colin Phipps

Blood · Singapore

Dr Colin Phipps is a haematologist practising at Mount Elizabeth Hospitals and Gleneagles Hospital, Singapore. He specialises in lymphoma and blood cancers, and haematopoietic stem cell transplantation. Dr Phipps received his medical degree from the National University of Ireland in 2002 and subsequently completed internal medicine residency and specialist training in haematology at Singapore General Hospital (SGH). He was awarded the HMDP fellowship to pursue subspecialty training in lymphoma and bone marrow transplantation at the renowned Fred Hutchinson Cancer Research Centre in Seattle. Dr Phipps spent 10 years with the department of haematology at SGH. There, he was appointed as lymphoma director in 2012 and helped build the lymphoma programme, later becoming the lymphoma lead for the SingHealth-DUKE Blood Cancer Centre, which brought together lymphoma teams from SGH and National Cancer Centre Singapore. He has overseen the management of hundreds of patients with complex blood cancers, including resistant lymphomas and those undergoing transplantation. He also headed numerous pharmaceutical-sponsored and investigator-initiated clinical trials that have allowed patients access to many novel treatments. Dr Phipps is actively involved in undergraduate and postgraduate training of young doctors in Singapore. He has held roles including postgraduate mentor and senior lecturer with NUS Yong Loo Lin School of Medicine, as well as MBBS examiner and assistant adjunct professor with DUKE-NUS Medical School. He has authored more than 30 papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as advisor to numerous regional and international expert panels and education programmes.

Diong Colin Phipps

Blood · Singapore

Dr Colin Phipps is a haematologist practising at Mount Elizabeth Hospitals and Gleneagles Hospital, Singapore. He specialises in lymphoma and blood cancers, and haematopoietic stem cell transplantation. Dr Phipps received his medical degree from the National University of Ireland in 2002 and subsequently completed internal medicine residency and specialist training in haematology at Singapore General Hospital (SGH). He was awarded the HMDP fellowship to pursue subspecialty training in lymphoma and bone marrow transplantation at the renowned Fred Hutchinson Cancer Research Centre in Seattle. Dr Phipps spent 10 years with the department of haematology at SGH. There, he was appointed as lymphoma director in 2012 and helped build the lymphoma programme, later becoming the lymphoma lead for the SingHealth-DUKE Blood Cancer Centre, which brought together lymphoma teams from SGH and National Cancer Centre Singapore. He has overseen the management of hundreds of patients with complex blood cancers, including resistant lymphomas and those undergoing transplantation. He also headed numerous pharmaceutical-sponsored and investigator-initiated clinical trials that have allowed patients access to many novel treatments. Dr Phipps is actively involved in undergraduate and postgraduate training of young doctors in Singapore. He has held roles including postgraduate mentor and senior lecturer with NUS Yong Loo Lin School of Medicine, as well as MBBS examiner and assistant adjunct professor with DUKE-NUS Medical School. He has authored more than 30 papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as advisor to numerous regional and international expert panels and education programmes.

Lee Yuh Shan

Blood · Singapore

Dr Lee Yuh Shan is a haematologist at Gleneagles Hospital and Mount Elizabeth Novena Hospital, Singapore. He specialises in malignant haematology such as lymphoma, leukaemia, myeloma and haematopoietic stem cells transplant. He developed his specialty in lymphoma at the National Institutes of Health (NIH) in Maryland, United States, where he had first-hand experience in seeing patients under clinical trial with new oral therapy in the treatment of chronic lymphocytic leukemia (CLL) and aggressive lymphoma. He contributed to the development and incorporation of new agents in the treatment of lymphoma, as well as the development of investigator-initiated trials for aggressive lymphoma in the department of haematology at the Singapore General Hospital (SGH). Dr Lee worked for 10 years at SGH. He was the director of the lymphoma service in their department of haematology from 2017, and was the lymphoma lead at the SingHealth Duke Blood Cancer Centre (SDBCC) from 2018. He is active in collaborative works locally under the SDBCC and Singapore Lymphoma Working Group, as well as regionally for CLL. In addition, he is involved in many pharmaceutical sponsored trials and investigator-initiated trials, most of which focus on new agents in lymphoma and myeloma. Dr Lee is active in undergraduate medical training. He is a senior clinical tutor for the Yong Loo Lin School of Medicine at NUS, and is an adjunct associate professor at the Duke-NUS Medical School. He is also a faculty member of the senior residency programme in haematology at SGH. He is an active speaker at regional haematology symposiums especially in CLL/lymphoma. He also contributes to lymphoma support group and Singapore World Lymphoma Day. He has published in many peer-reviewed journals and is a reviewer for peer-reviewed journals. He is also a member of SingHealth Institutional Review Board (IRB) and sat on several pharmaceutical advisory boards.